BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15733118)

  • 1. Successful treatment of chemo-refractory pulmonary metastases of renal pelvic cancer by second-line chemotherapy including gemcitabine followed by salvage surgery.
    Tadokoro M; Yonese J; Tsukamoto T; Okubo Y; Hanada E; Satoh Y; Nakagawa K; Ishikawa Y; Fukui I
    Int J Urol; 2005 Feb; 12(2):208-10. PubMed ID: 15733118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report].
    Tsukamoto T; Yonese J; Ishii N; Maezawa T; Fukui I
    Hinyokika Kiyo; 2002 Jul; 48(7):427-30. PubMed ID: 12229181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy.
    Han KS; Joung JY; Kim TS; Jeong IG; Seo HK; Chung J; Lee KH
    Br J Cancer; 2008 Jan; 98(1):86-90. PubMed ID: 18087289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Second line" polychemotherapy in metastatic urothelial cancer of the renal pelvis. Persisting partial remission by 18 treatment cycles of gemcitabine/paclitaxel after 24 treatment cycles gemcitabine/cisplatin "stable disease"].
    Bannowsky A; Wefer B; Naumann M; Hamann M; Hautmann S; Jünemann KP
    Urologe A; 2005 Aug; 44(8):915-7. PubMed ID: 15942775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
    Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
    Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
    Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
    BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
    J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
    Kojima Y; Takahi Y; Ichimaru N; Okumi M; Takahara S; Nonomura N
    BMC Res Notes; 2015 Feb; 8():25. PubMed ID: 25648269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.
    Fairey AS; Daneshmand S; Quinn D; Dorff T; Dorin R; Lieskovsky G; Schuckman A; Cai J; Miranda G; Skinner EC
    Urol Oncol; 2013 Nov; 31(8):1737-43. PubMed ID: 23141776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy.
    Kanai K; Kikuchi E; Ohigashi T; Miyajima A; Nakagawa K; Nakashima J; Oya M
    Int J Clin Oncol; 2008 Dec; 13(6):510-4. PubMed ID: 19093178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
    Sternberg CN; Calabrò F; Pizzocaro G; Marini L; Schnetzer S; Sella A
    Cancer; 2001 Dec; 92(12):2993-8. PubMed ID: 11753976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
    Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
    Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of recurrence and systemic metastasis of oral cancer successfully treated with combination chemotherapy of cisplatin and gemcitabine].
    Minami S; Komut K
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):215-7. PubMed ID: 15751635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.
    Dorff TB; Tsao-Wei D; Miranda G; Skinner DG; Stein JP; Quinn DI
    World J Urol; 2009 Feb; 27(1):39-44. PubMed ID: 19020886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
    Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S
    Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports].
    Hosomi T; Shibasaki N; Otsuka H; Uketa S; Makino Y; Shichiri Y
    Hinyokika Kiyo; 2023 Jul; 69(7):183-188. PubMed ID: 37558639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
    Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC
    JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.
    Msaouel P; Zhang M; Tu SM
    Clin Genitourin Cancer; 2017 Feb; 15(1):e73-e77. PubMed ID: 27692813
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
    Halim A; Abotouk N
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):60-5. PubMed ID: 22897883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.
    Shiraishi T; Nakamura T; Mikami K; Takaha N; Kawauchi A; Miki T
    Int J Clin Oncol; 2009 Oct; 14(5):436-41. PubMed ID: 19856053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.